Hemingway D M, Cooke T G, Warren H, Bessent R G, McKillop J H, McArdle C S
University Department of Surgery, Royal Infirmary, Glasgow, UK.
Nucl Med Commun. 1995 Oct;16(10):867-9. doi: 10.1097/00006231-199510000-00011.
The clinical usefulness of the hepatic perfusion index (HPI) at the time of presentation has been evaluated in patients with colorectal cancer. In 83 consecutive patients, the HPI was abnormally elevated in 34 of 37 (93%) patients with overt metastases. This study confirms that the HPI is elevated in most patients with overt hepatic metastases. Long-term follow-up of patients with abnormal HPI and no obvious liver metastases is continuing.
已对结直肠癌患者就诊时肝脏灌注指数（HPI）的临床实用性进行了评估。在连续83例患者中，37例有明显转移的患者中有34例（93%）HPI异常升高。这项研究证实，大多数有明显肝转移的患者HPI升高。对HPI异常且无明显肝转移的患者的长期随访仍在继续。
